Clinical Trial Update: An Investigator Initiated Prospective, Four Arms Randomized Comparative Study of Efficacy and Safety of Saroglitazar, Vitamin E and Life Style Modification in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)/ Non-alcoholic Steatohepatitis (NASH) [Phase 3]

View source ↗

Summary

Investigator-initiated Phase 3 randomized trial comparing saroglitazar, vitamin E, and lifestyle modification for NAFLD/NASH.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Lifestyle modification
• Saroglitazar (saroglitazar)
• Vitamin E (tocopherol)

Snippet

Sponsor: Asian Institute of Gastroenterology, India | Conditions: NAFLD | Phase 3 | Status: UNKNOWN